<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.reuters.com/~d/styles/itemcontent.css"?><rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>Reuters: Health News</title><link>http://www.reuters.com</link><description>Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.</description><language>en-us</language><copyright>All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks or trademarks of the Reuters group of companies around the world. © Reuters 2013</copyright><pubDate>Sat, 18 May 2013 21:50:09 GMT</pubDate><lastBuildDate>Sat, 18 May 2013 21:50:09 GMT</lastBuildDate><ttl>5</ttl><image><title>Reuters: Health News</title><url>http://www.reuters.com/resources_v2/images/reuters125.png</url><link>http://www.reuters.com</link></image><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.reuters.com/reuters/healthNews" /><feedburner:info uri="reuters/healthnews" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:feedFlare href="http://add.my.yahoo.com/rss?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews" src="http://us.i1.yimg.com/us.yimg.com/i/us/my/addtomyyahoo4.gif">Subscribe with My Yahoo!</feedburner:feedFlare><feedburner:feedFlare href="http://www.newsgator.com/ngs/subscriber/subext.aspx?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews" src="http://www.newsgator.com/images/ngsub1.gif">Subscribe with NewsGator</feedburner:feedFlare><feedburner:feedFlare href="http://feeds.my.aol.com/add.jsp?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews" src="http://o.aolcdn.com/favorites.my.aol.com/webmaster/ffclient/webroot/locale/en-US/images/myAOLButtonSmall.gif">Subscribe with My AOL</feedburner:feedFlare><feedburner:feedFlare href="http://www.bloglines.com/sub/http://feeds.reuters.com/reuters/healthNews" src="http://www.bloglines.com/images/sub_modern11.gif">Subscribe with Bloglines</feedburner:feedFlare><feedburner:feedFlare href="http://www.netvibes.com/subscribe.php?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews" src="http://www.netvibes.com/img/add2netvibes.gif">Subscribe with Netvibes</feedburner:feedFlare><feedburner:feedFlare href="http://fusion.google.com/add?feedurl=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews" src="http://buttons.googlesyndication.com/fusion/add.gif">Subscribe with Google</feedburner:feedFlare><feedburner:feedFlare href="http://www.pageflakes.com/subscribe.aspx?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews" src="http://www.pageflakes.com/ImageFile.ashx?instanceId=Static_4&amp;fileName=ATP_blu_91x17.gif">Subscribe with Pageflakes</feedburner:feedFlare><item><title>Saudi Arabia has another case of new coronavirus: WHO</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/RdJZ8srSY6g/story01.htm</link><description>LONDON (Reuters) - Saudi Arabia has reported another case of infection in a concentrated outbreak of a new strain of a virus that emerged in the Middle East last year and spread into Europe, the World Health Organization (WHO) said on Saturday.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c1b011d/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=RdJZ8srSY6g:toTUgZN2Yu0:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=RdJZ8srSY6g:toTUgZN2Yu0:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=RdJZ8srSY6g:toTUgZN2Yu0:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=RdJZ8srSY6g:toTUgZN2Yu0:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=RdJZ8srSY6g:toTUgZN2Yu0:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/RdJZ8srSY6g" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Sat, 18 May 2013 21:43:00 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/18/us-saudi-coronavirus-idUSBRE94H0CN20130518?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c1b011d/l/0L0Sreuters0N0Carticle0C20A130C0A50C180Cus0Esaudi0Ecoronavirus0EidUSBRE94H0ACN20A130A5180DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Lundbeck says drug shows improvement in depression symptoms</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/vUyr9pmwMKk/story01.htm</link><description>COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck and Japanese partner Takeda said on Saturday that data from clinical phase III studies with the antidepressant vortioxetine had shown significant improvement in patients' symptoms.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c196196/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=vUyr9pmwMKk:njPnG_ysn9E:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=vUyr9pmwMKk:njPnG_ysn9E:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=vUyr9pmwMKk:njPnG_ysn9E:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=vUyr9pmwMKk:njPnG_ysn9E:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=vUyr9pmwMKk:njPnG_ysn9E:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/vUyr9pmwMKk" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Sat, 18 May 2013 18:05:53 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/18/us-lundbeck-takeda-brintellix-idUSBRE94H0BC20130518?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c196196/l/0L0Sreuters0N0Carticle0C20A130C0A50C180Cus0Elundbeck0Etakeda0Ebrintellix0EidUSBRE94H0ABC20A130A5180DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Virus found in Iowa hog population, possibly beyond</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/zK1svAbiBJE/story01.htm</link><description>WASHINGTON (Reuters) - A potentially fatal hog virus, porcine epidemic diarrhea, has been found in the United States for the first time, government and private industry officials said on Friday, posing a new threat for the country's struggling pork producers.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c12eb19/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664175983/u/49/f/654207/c/35217/s/2c12eb19/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664175983/u/49/f/654207/c/35217/s/2c12eb19/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664175983/u/49/f/654207/c/35217/s/2c12eb19/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=zK1svAbiBJE:K7OThEUUcOc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=zK1svAbiBJE:K7OThEUUcOc:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=zK1svAbiBJE:K7OThEUUcOc:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=zK1svAbiBJE:K7OThEUUcOc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=zK1svAbiBJE:K7OThEUUcOc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/zK1svAbiBJE" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 17 May 2013 23:33:26 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/17/us-usda-hogs-virus-idUSBRE94G0VQ20130517?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c12eb19/l/0L0Sreuters0N0Carticle0C20A130C0A50C170Cus0Eusda0Ehogs0Evirus0EidUSBRE94G0AVQ20A130A5170DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Fever reducers don't slow children's recovery: study</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/SEYqUr0B5DU/story01.htm</link><description>NEW YORK (Reuters Health) - A review of past research finds that fever-reducing drugs have no effect on the speed of children's recovery from an infection, contrary to the fears of some doctors and parents.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c12ede5/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=SEYqUr0B5DU:Uhm-6DtvCn4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=SEYqUr0B5DU:Uhm-6DtvCn4:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=SEYqUr0B5DU:Uhm-6DtvCn4:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=SEYqUr0B5DU:Uhm-6DtvCn4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=SEYqUr0B5DU:Uhm-6DtvCn4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/SEYqUr0B5DU" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 17 May 2013 21:33:08 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/17/us-fever-childrens-idUSBRE94G0WG20130517?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c12ede5/l/0L0Sreuters0N0Carticle0C20A130C0A50C170Cus0Efever0Echildrens0EidUSBRE94G0AWG20A130A5170DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Death toll from new bird flu in China rises to 36: WHO</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/5E_Dsv-sNpQ/story01.htm</link><description>LONDON (Reuters) - Four more people in China have died from a new strain of bird flu, bringing the death toll from the H7N9 virus to 36 from 131 confirmed cases, the World Health Organization (WHO) said on Friday.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c124634/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=5E_Dsv-sNpQ:a9sndUcUjMo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=5E_Dsv-sNpQ:a9sndUcUjMo:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=5E_Dsv-sNpQ:a9sndUcUjMo:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=5E_Dsv-sNpQ:a9sndUcUjMo:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=5E_Dsv-sNpQ:a9sndUcUjMo:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/5E_Dsv-sNpQ" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 17 May 2013 20:26:55 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/17/us-birdflu-deaths-idUSBRE94G0U020130517?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c124634/l/0L0Sreuters0N0Carticle0C20A130C0A50C170Cus0Ebirdflu0Edeaths0EidUSBRE94G0AU0A20A130A5170DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Surgeons-in-training dislike new work hours: survey</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/dj7x5u6AeSI/story01.htm</link><description>NEW YORK (Reuters Health) - Most surgeons-in-training dislike new rules that limit how many hours they can work, according to a new study that also found the majority said they skirt the restrictions.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c126502/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=dj7x5u6AeSI:kH5GZi-ktZs:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=dj7x5u6AeSI:kH5GZi-ktZs:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=dj7x5u6AeSI:kH5GZi-ktZs:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=dj7x5u6AeSI:kH5GZi-ktZs:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=dj7x5u6AeSI:kH5GZi-ktZs:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/dj7x5u6AeSI" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 17 May 2013 19:45:24 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/17/us-surgeons-work-hours-idUSBRE94G0SN20130517?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c126502/l/0L0Sreuters0N0Carticle0C20A130C0A50C170Cus0Esurgeons0Ework0Ehours0EidUSBRE94G0ASN20A130A5170DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Higher-stakes soccer matches tied to more injuries</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/6vW2jhWZlKQ/story01.htm</link><description>NEW YORK (Reuters Health) - Soccer matches played at a high level of competition are more likely to result in injuries - and in more serious ones - compared to less important games, according to a new study.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c11cd0e/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=6vW2jhWZlKQ:mgOuIDHLtu8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=6vW2jhWZlKQ:mgOuIDHLtu8:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=6vW2jhWZlKQ:mgOuIDHLtu8:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=6vW2jhWZlKQ:mgOuIDHLtu8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=6vW2jhWZlKQ:mgOuIDHLtu8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/6vW2jhWZlKQ" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 17 May 2013 18:29:52 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/17/us-soccer-matches-idUSBRE94G0PN20130517?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c11cd0e/l/0L0Sreuters0N0Carticle0C20A130C0A50C170Cus0Esoccer0Ematches0EidUSBRE94G0APN20A130A5170DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Endometriosis more common in lean women: study</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/Nnb9O0dCc6U/story01.htm</link><description>NEW YORK (Reuters Health) - Heavy women are less likely to be diagnosed with endometriosis than their slimmer peers, according to a new study.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c11ff5c/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664587828/u/49/f/654207/c/35217/s/2c11ff5c/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664587828/u/49/f/654207/c/35217/s/2c11ff5c/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664587828/u/49/f/654207/c/35217/s/2c11ff5c/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=Nnb9O0dCc6U:SnUSv7NaTKU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=Nnb9O0dCc6U:SnUSv7NaTKU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=Nnb9O0dCc6U:SnUSv7NaTKU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=Nnb9O0dCc6U:SnUSv7NaTKU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=Nnb9O0dCc6U:SnUSv7NaTKU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/Nnb9O0dCc6U" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 17 May 2013 18:27:40 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/17/us-endometriosis-women-idUSBRE94G0PH20130517?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c11ff5c/l/0L0Sreuters0N0Carticle0C20A130C0A50C170Cus0Eendometriosis0Ewomen0EidUSBRE94G0APH20A130A5170DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Novo Nordisk says completes hemophilia drug trial</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/fAjdWawZyv8/story01.htm</link><description>COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said on Friday it had completed the first phase III trial of a hemophilia drug, N9-GP.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c0e46db/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=fAjdWawZyv8:2FtNh_iGeg4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=fAjdWawZyv8:2FtNh_iGeg4:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=fAjdWawZyv8:2FtNh_iGeg4:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=fAjdWawZyv8:2FtNh_iGeg4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=fAjdWawZyv8:2FtNh_iGeg4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/fAjdWawZyv8" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 17 May 2013 12:44:02 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/17/us-novonordisk-haemophilia-idUSBRE94G0E320130517?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c0e46db/l/0L0Sreuters0N0Carticle0C20A130C0A50C170Cus0Enovonordisk0Ehaemophilia0EidUSBRE94G0AE320A130A5170DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>EU watchdog backs Bayer acne drug for certain patients</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/_YQ5ZfKJhzE/story01.htm</link><description>LONDON (Reuters) - Bayer's acne pill Diane 35 and its generic versions are safe to use in certain women when other options have failed, the European Medicines Agency said on Friday.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c0e41b9/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=_YQ5ZfKJhzE:TPz9-GZCx48:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=_YQ5ZfKJhzE:TPz9-GZCx48:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=_YQ5ZfKJhzE:TPz9-GZCx48:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=_YQ5ZfKJhzE:TPz9-GZCx48:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=_YQ5ZfKJhzE:TPz9-GZCx48:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/_YQ5ZfKJhzE" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 17 May 2013 12:26:23 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/17/us-bayer-ema-idUSBRE94G0D420130517?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c0e41b9/l/0L0Sreuters0N0Carticle0C20A130C0A50C170Cus0Ebayer0Eema0EidUSBRE94G0AD420A130A5170DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Sanofi says will keep Toulouse research site</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/FpAeU_Mtv0g/story01.htm</link><description>PARIS (Reuters) - Sanofi said it would overhaul rather than exit its Toulouse research site, as it seeks to break an impasse with the French government which opposed the drugmaker's reorganization plans and the loss of jobs.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c0dfd1e/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=FpAeU_Mtv0g:oMIb-R_agzc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=FpAeU_Mtv0g:oMIb-R_agzc:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=FpAeU_Mtv0g:oMIb-R_agzc:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=FpAeU_Mtv0g:oMIb-R_agzc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=FpAeU_Mtv0g:oMIb-R_agzc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/FpAeU_Mtv0g" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 17 May 2013 12:19:29 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/17/us-sanofi-toulouse-idUSBRE94G0CY20130517?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c0dfd1e/l/0L0Sreuters0N0Carticle0C20A130C0A50C170Cus0Esanofi0Etoulouse0EidUSBRE94G0ACY20A130A5170DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Organ donor cards hard to implement in China, official says</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/mQhJqrPhYT0/story01.htm</link><description>BEIJING (Reuters) - A system of donor cards indicating consent for organ transplants will not work in China as families will insist on having the final say, and many people see nothing wrong in using organs from executed prisoners, an official said on Friday.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c0d3d91/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664574447/u/49/f/654207/c/35217/s/2c0d3d91/kg/342-363/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664574447/u/49/f/654207/c/35217/s/2c0d3d91/kg/342-363/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664574447/u/49/f/654207/c/35217/s/2c0d3d91/kg/342-363/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=mQhJqrPhYT0:SxVhqpIxntg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=mQhJqrPhYT0:SxVhqpIxntg:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=mQhJqrPhYT0:SxVhqpIxntg:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=mQhJqrPhYT0:SxVhqpIxntg:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=mQhJqrPhYT0:SxVhqpIxntg:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/mQhJqrPhYT0" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 17 May 2013 11:30:06 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/17/us-china-organs-idUSBRE94G0BE20130517?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c0d3d91/l/0L0Sreuters0N0Carticle0C20A130C0A50C170Cus0Echina0Eorgans0EidUSBRE94G0ABE20A130A5170DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Sanofi says myelofibrosis treatment study positive</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/OQmxz2-QYPA/story01.htm</link><description>PARIS (Reuters) - French drugmaker Sanofi said a late-stage Phase III trial of a drug designed to treat myelofibrosis led to positive results.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c090eeb/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=OQmxz2-QYPA:nRhZ8edgdEc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=OQmxz2-QYPA:nRhZ8edgdEc:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=OQmxz2-QYPA:nRhZ8edgdEc:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=OQmxz2-QYPA:nRhZ8edgdEc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=OQmxz2-QYPA:nRhZ8edgdEc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/OQmxz2-QYPA" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 17 May 2013 05:41:13 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/17/us-sanofi-trial-idUSBRE94G04M20130517?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c090eeb/l/0L0Sreuters0N0Carticle0C20A130C0A50C170Cus0Esanofi0Etrial0EidUSBRE94G0A4M20A130A5170DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Psychiatrists unveil their long-awaited diagnostic "bible"</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/OrCXN01ZCuk/story01.htm</link><description>NEW YORK (Reuters) - The long-awaited, controversial new edition of the bible of psychiatry can be characterized by many numbers: its 947 pages, its $199 price tag, its more than 300 maladies (from "dependent personality disorder" and "voyeuristic disorder" to "delayed ejaculation," "kleptomania" and "intermittent explosive disorder"), each limning the potential woes of being human.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c08b3eb/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=OrCXN01ZCuk:B2_-xxCJfxY:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=OrCXN01ZCuk:B2_-xxCJfxY:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=OrCXN01ZCuk:B2_-xxCJfxY:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=OrCXN01ZCuk:B2_-xxCJfxY:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=OrCXN01ZCuk:B2_-xxCJfxY:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/OrCXN01ZCuk" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Fri, 17 May 2013 04:05:23 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/17/us-science-psychiatry-dsm-idUSBRE94G04420130517?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c08b3eb/l/0L0Sreuters0N0Carticle0C20A130C0A50C170Cus0Escience0Epsychiatry0Edsm0EidUSBRE94G0A4420A130A5170DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>British team hails new embryo selection method for IVF success</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/7QUBoWv-RS4/story01.htm</link><description>LONDON (Reuters) - British fertility experts have devised a new IVF technique that takes thousands of snapshots of a developing embryo that they say can help doctors pick those most likely to implant successfully and develop into healthy babies.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c071eec/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=7QUBoWv-RS4:xA3nnX-x7MQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=7QUBoWv-RS4:xA3nnX-x7MQ:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=7QUBoWv-RS4:xA3nnX-x7MQ:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=7QUBoWv-RS4:xA3nnX-x7MQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=7QUBoWv-RS4:xA3nnX-x7MQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/7QUBoWv-RS4" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 16 May 2013 23:25:26 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/16/us-ivf-embryos-idUSBRE94F1DB20130516?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c071eec/l/0L0Sreuters0N0Carticle0C20A130C0A50C160Cus0Eivf0Eembryos0EidUSBRE94F1DB20A130A5160DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>U.S. House votes to repeal Obamacare in 37th symbolic act</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/a0hGvKDjJaw/story01.htm</link><description>WASHINGTON (Reuters) - The Republican-controlled U.S. House of Representatives voted to repeal President Barack Obama's healthcare reform law on Thursday in a symbolic move aimed as much at healing internal Republican rifts as demonstrating dogged party opposition to "Obamacare."&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c06f98d/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664555034/u/49/f/654207/c/35217/s/2c06f98d/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664555034/u/49/f/654207/c/35217/s/2c06f98d/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664555034/u/49/f/654207/c/35217/s/2c06f98d/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=a0hGvKDjJaw:qf7LcHQePa8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=a0hGvKDjJaw:qf7LcHQePa8:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=a0hGvKDjJaw:qf7LcHQePa8:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=a0hGvKDjJaw:qf7LcHQePa8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=a0hGvKDjJaw:qf7LcHQePa8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/a0hGvKDjJaw" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 16 May 2013 23:03:33 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/16/us-usa-healthcare-repeal-idUSBRE94F1CE20130516?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c06f98d/l/0L0Sreuters0N0Carticle0C20A130C0A50C160Cus0Eusa0Ehealthcare0Erepeal0EidUSBRE94F1CE20A130A5160DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Multiple concussions tied to more suicidal thoughts</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/USm2gnW21v4/story01.htm</link><description>NEW YORK (Reuters Health) - People who've sustained multiple brain injuries throughout their life were more likely to report suicidal thoughts than people with one or no concussions, according to a new study of deployed U.S. military personnel.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c065b39/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=USm2gnW21v4:kWJmy27GJxA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=USm2gnW21v4:kWJmy27GJxA:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=USm2gnW21v4:kWJmy27GJxA:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=USm2gnW21v4:kWJmy27GJxA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=USm2gnW21v4:kWJmy27GJxA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/USm2gnW21v4" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 16 May 2013 21:03:36 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/16/us-concussions-suicidal-idUSBRE94F17320130516?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c065b39/l/0L0Sreuters0N0Carticle0C20A130C0A50C160Cus0Econcussions0Esuicidal0EidUSBRE94F17320A130A5160DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Up to 1 in 5 children suffer from mental disorder: CDC</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/g01h6s7zRTw/story01.htm</link><description>NEW YORK (Reuters) - Up to 20 percent of children in the United States suffer from a mental disorder, and the number of kids diagnosed with one has been rising for more than a decade, according to a report released on Thursday by the U.S. Center for Disease Control and Prevention.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c05f39e/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=g01h6s7zRTw:Ri_-rUC36x8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=g01h6s7zRTw:Ri_-rUC36x8:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=g01h6s7zRTw:Ri_-rUC36x8:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=g01h6s7zRTw:Ri_-rUC36x8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=g01h6s7zRTw:Ri_-rUC36x8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/g01h6s7zRTw" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 16 May 2013 19:46:25 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/16/us-usa-health-children-idUSBRE94F11N20130516?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c05f39e/l/0L0Sreuters0N0Carticle0C20A130C0A50C160Cus0Eusa0Ehealth0Echildren0EidUSBRE94F11N20A130A5160DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Lifestyle change may ease heart risk from job stress</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/c5mqdioppK8/story01.htm</link><description>NEW YORK (Reuters Health) - Being under stress at work is tied to a higher risk of heart problems, new research confirms - but putting down the beer bottle and going for a walk may help.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c05f164/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=c5mqdioppK8:afjltG635Iw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=c5mqdioppK8:afjltG635Iw:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=c5mqdioppK8:afjltG635Iw:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=c5mqdioppK8:afjltG635Iw:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=c5mqdioppK8:afjltG635Iw:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/c5mqdioppK8" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 16 May 2013 19:33:29 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/16/us-lifestyle-heart-risk-idUSBRE94F12420130516?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c05f164/l/0L0Sreuters0N0Carticle0C20A130C0A50C160Cus0Elifestyle0Eheart0Erisk0EidUSBRE94F12420A130A5160DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Data show new Roche leukemia drug may improve on Rituxan</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/LFkAINFquWY/story01.htm</link><description>(Reuters) - An experimental leukemia treatment that Roche Holding AG hopes will improve upon its best-selling cancer drug Rituxan delayed disease progression twice as long as chemotherapy, according to preliminary trial data released on Wednesday.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c05f166/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664230870/u/49/f/654207/c/35217/s/2c05f166/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664230870/u/49/f/654207/c/35217/s/2c05f166/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664230870/u/49/f/654207/c/35217/s/2c05f166/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=LFkAINFquWY:9JJYMeqsh8A:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=LFkAINFquWY:9JJYMeqsh8A:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=LFkAINFquWY:9JJYMeqsh8A:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=LFkAINFquWY:9JJYMeqsh8A:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=LFkAINFquWY:9JJYMeqsh8A:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/LFkAINFquWY" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 16 May 2013 19:25:56 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/16/us-cancer-roche-leukemia-idUSBRE94F11S20130516?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c05f166/l/0L0Sreuters0N0Carticle0C20A130C0A50C160Cus0Ecancer0Eroche0Eleukemia0EidUSBRE94F11S20A130A5160DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Can sleep at altitude prevent sudden hiker deaths?</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/3Zvtq6AvBH4/story01.htm</link><description>NEW YORK (Reuters Health) - Men who die of a sudden cardiac event are less likely to do so on the first day of mountain activities if they sleep at higher elevations the night before, according to a new study.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c057df9/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=3Zvtq6AvBH4:LGHoNm2qd5o:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=3Zvtq6AvBH4:LGHoNm2qd5o:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=3Zvtq6AvBH4:LGHoNm2qd5o:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=3Zvtq6AvBH4:LGHoNm2qd5o:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=3Zvtq6AvBH4:LGHoNm2qd5o:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/3Zvtq6AvBH4" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 16 May 2013 19:03:46 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/16/us-sleep-altitude-idUSBRE94F10S20130516?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c057df9/l/0L0Sreuters0N0Carticle0C20A130C0A50C160Cus0Esleep0Ealtitude0EidUSBRE94F10AS20A130A5160DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Combined supplements no better for cholesterol</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/vU04Lk5r0po/story01.htm</link><description>NEW YORK (Reuters Health) - Adding a plant-derived compound called a sterol to the cholesterol-lowering agent red yeast rice doesn't make it work any better, according to a new study.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c052d89/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=vU04Lk5r0po:IEGr2TUInFo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=vU04Lk5r0po:IEGr2TUInFo:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=vU04Lk5r0po:IEGr2TUInFo:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=vU04Lk5r0po:IEGr2TUInFo:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=vU04Lk5r0po:IEGr2TUInFo:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/vU04Lk5r0po" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 16 May 2013 17:44:57 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/16/us-combined-supplements-idUSBRE94F0WX20130516?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c052d89/l/0L0Sreuters0N0Carticle0C20A130C0A50C160Cus0Ecombined0Esupplements0EidUSBRE94F0AWX20A130A5160DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Over 20 South African boys die in circumcision rituals: police</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/bNzGLwWJCTk/story01.htm</link><description>JOHANNESBURG (Reuters) - More than 20 South African boys have died over the past week during coming of age rituals, police said on Thursday, and they blamed botched circumcisions as the likely cause of death.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c045cf6/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=bNzGLwWJCTk:rUok2b57mtE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=bNzGLwWJCTk:rUok2b57mtE:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=bNzGLwWJCTk:rUok2b57mtE:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=bNzGLwWJCTk:rUok2b57mtE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=bNzGLwWJCTk:rUok2b57mtE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/bNzGLwWJCTk" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 16 May 2013 16:55:44 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/16/us-safrica-circumcision-idUSBRE94F0U320130516?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c045cf6/l/0L0Sreuters0N0Carticle0C20A130C0A50C160Cus0Esafrica0Ecircumcision0EidUSBRE94F0AU320A130A5160DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Swedish drug maker Recipharm looks to list or sell stake-source</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/FbN3DScvz-s/story01.htm</link><description>STOCKHOLM (Reuters) - Sweden's Recipharm has hired UBS to advise on either a partial sale of the pharmaceutical company or a listing on the Stockholm exchange, a source close to the process told Reuters on Thursday.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c03b2c7/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664032294/u/49/f/654207/c/35217/s/2c03b2c7/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664032294/u/49/f/654207/c/35217/s/2c03b2c7/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664032294/u/49/f/654207/c/35217/s/2c03b2c7/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=FbN3DScvz-s:sEMTufsNcBg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=FbN3DScvz-s:sEMTufsNcBg:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=FbN3DScvz-s:sEMTufsNcBg:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=FbN3DScvz-s:sEMTufsNcBg:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=FbN3DScvz-s:sEMTufsNcBg:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/FbN3DScvz-s" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 16 May 2013 16:00:05 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/16/us-recipharm-ipo-idUSBRE94F0RF20130516?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c03b2c7/l/0L0Sreuters0N0Carticle0C20A130C0A50C160Cus0Erecipharm0Eipo0EidUSBRE94F0ARF20A130A5160DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Warning didn't change for-profit dialysis drug use</title><link>http://feeds.reuters.com/~r/reuters/healthNews/~3/jF1LV-IuJME/story01.htm</link><description>NEW YORK (Reuters Health) - Despite a strong warning from U.S. regulators in 2007, for-profit dialysis centers still gave their kidney failure patients more of a certain anemia drug than non-profit centers in 2008, says a new study.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c017e7c/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=jF1LV-IuJME:dxs8C1wtjKI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=jF1LV-IuJME:dxs8C1wtjKI:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=jF1LV-IuJME:dxs8C1wtjKI:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=jF1LV-IuJME:dxs8C1wtjKI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=jF1LV-IuJME:dxs8C1wtjKI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/jF1LV-IuJME" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Thu, 16 May 2013 13:07:06 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/16/us-warning-profit-dialysis-idUSBRE94F0KU20130516?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c017e7c/l/0L0Sreuters0N0Carticle0C20A130C0A50C160Cus0Ewarning0Eprofit0Edialysis0EidUSBRE94F0AKU20A130A5160DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item></channel></rss>
